Forecasting cardiovascular risk reduction with semaglutide in overweight and obese with heart disease: a nationwide cohort study

Mats C Højbjerg Lassen; Kristoffer Grundtvig Skaarup; Muthiah Vaduganathan; John W Ostrominski; Jens Ulrik Stæhr Jensen; Tor Biering-Sørensen; Niklas Dyrby Johansen

doi:10.1093/eurjpc/zwae224

Forecasting cardiovascular risk reduction with semaglutide in overweight and obese with heart disease: a nationwide cohort study

Mats C Højbjerg Lassen^*, Kristoffer Grundtvig Skaarup, Muthiah Vaduganathan, John W Ostrominski, Jens Ulrik Stæhr Jensen, Tor Biering-Sørensen, Niklas Dyrby Johansen

^*Corresponding author af dette arbejde

1 Citationer (Scopus)

Originalsprog	Engelsk
Artikelnummer	zwae224
Tidsskrift	European Journal of Preventive Cardiology
Vol/bind	32
Udgave nummer	3
Sider (fra-til)	259-261
Antal sider	3
ISSN	2047-4873
DOI	https://doi.org/10.1093/eurjpc/zwae224
Status	Udgivet - 18 feb. 2025

Adgang til dokumentet

10.1093/eurjpc/zwae224

Andre filer og links

Link to publication in Scopus

Citationsformater

Lassen, M. C. H., Skaarup, K. G., Vaduganathan, M., Ostrominski, J. W., Jensen, J. U. S., Biering-Sørensen, T., & Johansen, N. D. (2025). Forecasting cardiovascular risk reduction with semaglutide in overweight and obese with heart disease: a nationwide cohort study. European Journal of Preventive Cardiology, 32(3), 259-261. Artikel zwae224. https://doi.org/10.1093/eurjpc/zwae224

Forecasting cardiovascular risk reduction with semaglutide in overweight and obese with heart disease: a nationwide cohort study. / Lassen, Mats C Højbjerg; Skaarup, Kristoffer Grundtvig; Vaduganathan, Muthiah et al.
I: European Journal of Preventive Cardiology, Bind 32, Nr. 3, zwae224, 18.02.2025, s. 259-261.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{85c5ecd333d048da9e77aa979579d722,

title = "Forecasting cardiovascular risk reduction with semaglutide in overweight and obese with heart disease: a nationwide cohort study",

author = "Lassen, {Mats C H{\o}jbjerg} and Skaarup, {Kristoffer Grundtvig} and Muthiah Vaduganathan and Ostrominski, {John W} and Jensen, {Jens Ulrik St{\ae}hr} and Tor Biering-S{\o}rensen and Johansen, {Niklas Dyrby}",

year = "2025",

month = feb,

day = "18",

doi = "10.1093/eurjpc/zwae224",

language = "English",

volume = "32",

pages = "259--261",

journal = "European Journal of Preventive Cardiology",

issn = "2047-4873",

publisher = "Sage Publications Ltd",

number = "3",

}

TY - JOUR

T1 - Forecasting cardiovascular risk reduction with semaglutide in overweight and obese with heart disease

T2 - a nationwide cohort study

AU - Lassen, Mats C Højbjerg

AU - Skaarup, Kristoffer Grundtvig

AU - Vaduganathan, Muthiah

AU - Ostrominski, John W

AU - Jensen, Jens Ulrik Stæhr

AU - Biering-Sørensen, Tor

AU - Johansen, Niklas Dyrby

PY - 2025/2/18

Y1 - 2025/2/18

UR - http://www.scopus.com/inward/record.url?scp=85218107656&partnerID=8YFLogxK

U2 - 10.1093/eurjpc/zwae224

DO - 10.1093/eurjpc/zwae224

M3 - Journal article

C2 - 39021164

SN - 2047-4873

VL - 32

SP - 259

EP - 261

JO - European Journal of Preventive Cardiology

JF - European Journal of Preventive Cardiology

IS - 3

M1 - zwae224

ER -